Private Equity

Managers

Mayfield bulks up its team as it celebrates 50 years of investing

2 min read · 09 January 2019

Optum Ventures backs AbleTo

AbleTo, a provider of virtual behavioral health care, has secured an undisclosed amount of funding. The investor was Optum Ventures.

1 min read · 08 January 2019

Keros Therapeutics nets $23 mln Series B

Lexington, Massachusetts-based Keros Therapeutics, which is focused on developing treatments for neuromuscular diseases, has raised $23 million in Series B financing. The investors included Pontifax, Arkin Bio Ventures, Partners Innovation Fund, Medison Pharma and Global Health Sciences Fund.

1 min read · 08 January 2019

Stelexis Therapeutics procures $43 mln Series A

New York-based Stelexis Therapeutics, a cancer therapeutics firm, has secured $43 million in Series A financing. Stelexis is backed by Deerfield.

1 min read · 08 January 2019

Apollomics racks up $100 mln Series B

Apollomics Inc, a biopharmaceutical company focused on oncology combination therapies, has raised $100 million in Series B financing. CMB International led the round with participation from other investors that included OrbiMed Asia.

1 min read · 08 January 2019

Spring Lake leads Series A round for Forefront Telecare

Novato, California-based Forefront Telecare Inc, a provider of behavioral telehealth services to seniors in rural facilities in the U.S., has raised an undisclosed amount of Series A funding. Spring Lake Equity Partners led the round.

1 min read · 08 January 2019

Cherry Ventures targets over $200.7 mln for third U.S. fund

Cherry Ventures is seeking to raise over $200.7 million for its third U.S. fund, according to an SEC filing. Based in Berlin, Cherry Ventures makes seed investments.

1 min read · 08 January 2019

GreenLight Biosciences grabs $50 mln

Boston-based GreenLight Biosciences Inc, a developer of RNA-based solutions for agriculture and pharmaceutical applications, has secured $50 million in funding. S2G Ventures, Baird Capital and Blue I/O led the round.

1 min read · 08 January 2019

Israeli biotech firm Biond Biologics lands $17 mln Series B

Biond Biologics Ltd, an Israeli biotechnology company, has secured $17 million in Series B financing. Israel Biotech Fund and Harel Insurance & Finance Group led the round with participation from other investors that included Celgene Corporation and SBI JI Innovation Fund.

1 min read · 08 January 2019

Israel 2018: Startup Nation begins move to Scale-Up Nation with later rounds

4 min read · 08 January 2019

Showing 2,851 to 2,860 of 19,970 results
1…285287…1000